10 Biggest Price Target Changes For Monday

  • Morgan Stanley cut Guardant Health, Inc. GH price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.
  • Oppenheimer cut the price target for Relmada Therapeutics, Inc. RLMD from $75 to $64. Relmada Therapeutics shares fell 5.2% to close at $21.23 on Friday.
  • Mizuho raised the price target on McKesson Corporation MCK from $280 to $331. McKesson shares fell 0.8% to $331.36 in pre-market trading.
  • Credit Suisse boosted the price target for Kellogg Company K from $62 to $69. Kellogg shares fell 1.4% to $71.70 in pre-market trading.
  • Barclays boosted the price target on EPAM Systems, Inc. EPAM from $350 to $410. EPAM Systems shares fell 3.7% to $334.03 in pre-market trading.

Check out this: Snap And 2 Other Stocks Insiders Are Selling

  • Wells Fargo raised the price target on Cigna Corporation CI from $278 to $306. Cigna shares fell 0.7% to $265.00 in pre-market trading.
  • Citigroup reduced Lucid Group, Inc. LCID price target from $45 to $36. Lucid Group shares fell 4% to $17.42 in pre-market trading.
  • Truist Securities reduced Virgin Galactic Holdings, Inc. SPCE price target from $24 to $8. Virgin Galactic shares fell 3.9% to $6.53 in pre-market trading.
  • JMP Securities cut Intellia Therapeutics, Inc. NTLA price target from $165 to $110. Intellia Therapeutics shares dropped 5.2% to $45.07 in pre-market trading.
  • Telsey Advisory Group lowered Under Armour, Inc. UAA price target from $25 to $17. Under Armour shares fell 1% to $10.78 in pre-market trading.

Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Price TargetSmall CapPre-Market OutlookAnalyst RatingsHealth CareHealth Care DistributorsPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!